Skin Cancer & Melanoma

Latest News

Cosibelimab has been approved by the FDA as a treatment for patients with cutaneous squamous cell carcinoma.
FDA Approves Cosibelimab in Cutaneous Squamous Cell Carcinoma

December 13th 2024

Cosibelimab has been approved by the FDA as a treatment for patients with cutaneous squamous cell carcinoma.

Vusolimogene oderparepvec in combination with nivolumab has received breakthrough therapy designation from the FDA in advanced melanoma.
FDA Assigns BTD and Receives BLA for RP1 Combo in Advanced Melanoma

November 22nd 2024

IMA203 Shows Frequent, Enduring Responses and Tolerability in Melanoma
IMA203 Shows Frequent, Enduring Responses and Tolerability in Melanoma

November 8th 2024

Phase 3 data may support the photodynamic therapy as a noninvasive treatment option for patients with superficial basal cell carcinoma.
Novel Photodynamic Therapy Yields Clearance in Basal Cell Carcinoma

November 4th 2024

Phase 1b findings may affirm the therapeutic potential of IMA203 for patients with previously treated metastatic melanoma.
PRAME-Targeted Agent Shows Activity in Pretreated Metastatic Melanoma

October 14th 2024

Video Series
Video Interviews
Podcasts
OncView™ Podcast: Immunotherapy Response Monitoring in Melanoma
On this episode of CancerNetwork’s podcast, Emily Smith, MD, discussed a patient case of basal cell carcinoma she and colleagues published in the journal ONCOLOGY.

More News